ABSTRACT: The herbal drug aristolochic acid, a natural mixture of 8-methoxy-6-nitrophenanthro[3,4-d]-1,3-dioxole-5-carboxylic acid (AAI) and 6-nitrophenanthro[3,4-d]-1,3-dioxole-5-carboxylic acid (AAII), is derived from Aristolochia species and is the cause of two nephropathies. Ingestion of aristolochic acid is associated with the development of urothelial tumors linked with aristolochic acid nephropathy and is implicated in the development of Balkan endemic nephropathy-associated urothelial tumors. The O-demethylated metabolite of AAI, 8-hydroxyaristolochic acid (AAIa), is the detoxification product of AAI generated by its oxidative metabolism. Whereas the formation of AAIa from AAI by cytochrome P450 (CYP) enzymes has been found in vitro and in vivo, this metabolite has not been found from AAII as yet. Therefore, the present study has been designed to compare the amenability of AAI and AAII to oxidation; experimental and theoretical approaches were used for such a study. In the case of experimental approaches, the enzyme (CYP)-mediated formation of AAIa from both carcinogens was investigated using CYP enzymes present in subcellular microsomal fractions and recombinant CYP enzymes. We found that in contrast to AAI, AAII is oxidized only by several CYP enzymatic systems and their efficiency is much lower for oxidation of AAII than AAI. Using the theoretical approaches, such as flexible in silico docking methods and ab initio calculations, contribution to explanation of these differences was established. Indeed, the results found by both used approaches determined the reasons why AAI is better oxidized than AAII; the key factor causing the differences in AAI and AAII oxidation is their different amenability to chemical oxidation.

Analytical and Environmental Sciences Division MRC PHE Centre for Environment and Health King's College London London SE1 9NH UK

Department of Biochemistry Faculty of Science Charles University Albertov 2030 128 40 Prague 2 Czech Republic

Division of Radiopharmaceutical Chemistry German Cancer Research Center Im Neuenheimer Feld 280 69120 Heidelberg Germany

NIHR Health Protection Research Unit in Health Impact of Environmental Hazards at King's College London in Partnership with Public Health England London SE1 9NH UK

Zobrazit více v PubMed

Arlt VM, Stiborova M, Schmeiser HH. Mutagenesis. 2002;17:265. doi: 10.1093/mutage/17.4.265. PubMed DOI

Arlt VM, Stiborova M, vom Brocke J, Simões ML, Lord GM, Nortier JL, Hollstein M, Phillips DH, Schmeiser HH. Carcinogenesis. 2007;28:2253. doi: 10.1093/carcin/bgm082. PubMed DOI

Stiborová M, Frei E, Arlt VM, Schmeiser HH. Mutat Res. 2008;658:55. doi: 10.1016/j.mrrev.2007.07.003. PubMed DOI

Stiborová M, Frei E, Schmeiser HH. Kidney Int. 2008;73:1209. doi: 10.1038/ki.2008.125. PubMed DOI

Stiborova M, Martinek V, Frei E, Arlt VM, Schmeiser HH. Curr Drug Metab. 2013;14:695. doi: 10.2174/1389200211314060006. PubMed DOI

Stiborová M, Arlt VM, Schmeiser HH. Arch Toxicol. 2016;90:2595. doi: 10.1007/s00204-016-1819-3. PubMed DOI PMC

Schmeiser HH, Stiborova M, Arlt VM. Curr Opin Drug Discov Dev. 2009;12:141. PubMed

Gökmen MR, Cosyns JP, Arlt VM, Stiborová M, Phillips DH, Schmeiser HH, Simmonds MS, Cook HT, Vanherweghem JL, Nortier JL, Lord GM. Ann Intern Med. 2013;158:469. doi: 10.7326/0003-4819-158-6-201303190-00006. PubMed DOI

Grollman AP. Environ Mol Mutagen. 2013;54:1. doi: 10.1002/em.21756. PubMed DOI

Schmeiser HH, Pool BL, Wiessler M. Cancer Lett. 1984;23:97. doi: 10.1016/0304-3835(84)90067-3. PubMed DOI

Kohara A, Suzuki T, Honma M, Ohwada T, Hayashi M. Mutat Res. 2002;515:63. doi: 10.1016/S1383-5718(01)00350-3. PubMed DOI

Nortier JL, Martinez MC, Schmeiser HH, Arlt VM, Bieler CA, Petein M, Depierreux MF, De Pauw L, Abramowicz D, Vereerstraeten P, Vanherweghem JL. N Engl J Med. 2000;342:1686. doi: 10.1056/NEJM200006083422301. PubMed DOI

Mei N, Arlt VM, Phillips DH, Heflich RH, Chen T. Mutat Res. 2006;602:83. doi: 10.1016/j.mrfmmm.2006.08.004. PubMed DOI PMC

International Agency for Research on Cancer (IARC) Environ. Health criteria monographs. Geneva: World Health Organization; 2012.

Schmeiser HH, Kucab JE, Arlt VM, Phillips DH, Hollstein M, Gluhovschi G, Gluhovschi C, Modilca M, Daminescu L, Petrica L, Velciov S. Environ Mol Mutagen. 2012;53:636. doi: 10.1002/em.21732. PubMed DOI

Krumbiegel G, Hallensleben J, Mennicke WH, Rittmann N, Roth HJ. Xenobiotica. 1987;17:981. doi: 10.3109/00498258709044197. PubMed DOI

Chan W, Cui L, Xu G, Cai Z. Rapid Commun Mass Spectrom. 2006;20:1755. doi: 10.1002/rcm.2513. PubMed DOI

Chan W, Luo HB, Zheng Y, Cheng YK, Cai Z. Drug Metab Dispos. 2007;35:866. doi: 10.1124/dmd.106.013979. PubMed DOI

Schmeiser HH, Schoepe KB, Wiessler M. Carcinogenesis. 1988;9:297. doi: 10.1093/carcin/9.2.297. PubMed DOI

Pfau W, Schmeiser HH, Wiessler M. Carcinogenesis. 1990;11:1627. doi: 10.1093/carcin/11.9.1627. PubMed DOI

Stiborová M, Fernando RC, Schmeiser HH, Frei E, Pfau W, Wiessler M. Carcinogenesis. 1994;15:1187. doi: 10.1093/carcin/15.6.1187. PubMed DOI

Shibutani S, Dong H, Suzuki N, Ueda S, Miller F, Grollman AP. Drug Metab Dispos. 2007;35:1217. doi: 10.1124/dmd.107.014688. PubMed DOI

Arlt VM, Meinl W, Florian S, Nagy E, Barta F, Thomann M, Mrizova I, Krais AM, Liu M, Richards M, Mirza A, Kopka K, Phillips DH, Glatt H, Stiborova M, Schmeiser HH. Arch Toxicol. 2017;91:1957. doi: 10.1007/s00204-016-1808-6. PubMed DOI PMC

Schmeiser HH, Frei E, Wiessler M, Stiborova M. Carcinogenesis. 1997;18:1055. doi: 10.1093/carcin/18.5.1055. PubMed DOI

Stiborova M, Frei E, Wiessler M, Schmeiser HH. Chem Res Toxicol. 2001;14:1128. doi: 10.1021/tx010059z. PubMed DOI

Stiborova M, Hajek M, Frei E, Schmeiser HH. Gen Physiol Biophys. 2001;20:375. PubMed

Stiborová M, Frei E, Breuer A, Wiessler M, Schmeiser HH. Mutat Res. 2001;493:149. doi: 10.1016/S1383-5718(01)00171-1. PubMed DOI

Stiborova M, Frei E, Sopko B, Wiessler M, Schmeiser HH. Carcinogenesis. 2002;23:617. doi: 10.1093/carcin/23.4.617. PubMed DOI

Martinek V, Kubickova B, Arlt VM, Frei E, Schmeiser HH, Hudecek J, Stiborova M. Neuro Endocrinol Lett. 2011;32:57. PubMed

Stiborová M, Hudeček J, Frei E, Schmeiser HH. Interdiscip Toxicol. 2008;1:8. doi: 10.2478/v10102-010-0023-1. PubMed DOI PMC

Stiborová M, Frei E, Sopko B, Sopková K, Marková V, Lanková M, Kumstýrová T, Wiessler M, Schmeiser HH. Carcinogenesis. 2003;24:1695. doi: 10.1093/carcin/bgg119. PubMed DOI

Stiborova M, Frei E, Hodek P, Wiessler M, Schmeiser HH. Int J Cancer. 2005;113:189. doi: 10.1002/ijc.20564. PubMed DOI

Stiborova M, Levova K, Barta F, Shi Z, Frei E, Schmeiser HH, Nebert DW, Phillips DH, Arlt VM. Toxicol Sci. 2012;125:345. doi: 10.1093/toxsci/kfr306. PubMed DOI PMC

Arlt VM, Levova K, Barta F, Shi Z, Evans JD, Frei E, Schmeiser HH, Nebert DW, Phillips DH, Stiborová M. Chem Res Toxicol. 2011;24:1710. doi: 10.1021/tx200259y. PubMed DOI

Arlt VM, Henderson CJ, Wolf CR, Stiborova M, Phillips DH. Toxicol Res. 2015;4:548. doi: 10.1039/C4TX00116H. DOI

Sistkova J, Hudecek J, Hodek P, Frei E, Schmeiser HH, Stiborova M. Neuro Endocrinol Lett. 2008;29:733. PubMed

Rosenquist TA, Einolf HJ, Dickman KG, Wang L, Smith A, Grollman AP. Drug Metab Dispos. 2010;38:761. doi: 10.1124/dmd.110.032201. PubMed DOI PMC

Levová K, Moserová M, Kotrbová V, Sulc M, Henderson CJ, Wolf CR, Phillips DH, Frei E, Schmeiser HH, Mares J, Arlt VM, Stiborová M. Toxicol Sci. 2011;121:43. doi: 10.1093/toxsci/kfr050. PubMed DOI

Stiborová M, Bárta F, Levová K, Hodek P, Schmeiser HH, Arlt VM, Martínek V. Int J Mol Sci. 2015;16:27561. doi: 10.3390/ijms161126047. PubMed DOI PMC

Dračínská H, Bárta F, Levová K, Hudecová A, Moserová M, Schmeiser HH, Kopka K, Frei E, Arlt VM, Stiborová M. Toxicology. 2016;346:7. doi: 10.1016/j.tox.2016.01.011. PubMed DOI PMC

Rittle J, Green MT. Science. 2010;330:933. doi: 10.1126/science.1193478. PubMed DOI

Jung C, de Vries S, Schünemann V. Arch Biochem Biophys. 2011;507:44. doi: 10.1016/j.abb.2010.12.029. PubMed DOI

Gut I, Nedelcheva V, Soucek P, Stopka P, Vodicka P, Gelboin HV, Ingelman-Sundberg M. Arch Toxicol. 1996;71:45. doi: 10.1007/s002040050357. PubMed DOI

Chirulli V, Longo V, Marini S, Mazzaccaro A, Fiorio R, Gervasi PG. Life Sci. 2005;76:2535. doi: 10.1016/j.lfs.2004.09.042. PubMed DOI

Wiechelman KJ, Braun RD, Fitzpatrick JD. Anal Biochem. 1988;75:231. doi: 10.1016/0003-2697(88)90383-1. PubMed DOI

Dixon M. Biochem J. 1953;55:150.

Walsh AA, Szklarz GD, Scott EE. J Biol Chem. 2013;288:12932. doi: 10.1074/jbc.M113.452953. PubMed DOI PMC

Sansen S, Yano JK, Reynald RL, Schoch GA, Griffin KJ, Stout CD, Johnson EF. J Biol Chem. 2007;282:14348. doi: 10.1074/jbc.M611692200. PubMed DOI

Pontikis G, Borden J, Martínek V, Florián J. J Phys Chem A. 2009;113:3588. doi: 10.1021/jp808928f. PubMed DOI

Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Montgomery JA, Jr, Vreven T, Kudin KN, Burant JC, Millam JM, Iyengar SS, Tomasi J, Barone V, Mennucci B, Cossi M, Scalmani G, Rega N, Petersson GA, Nakatsuji H, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Klene M, Li X, Knox JE, Hratchian HP, Cross JB, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Ayala PY, Morokuma K, Voth GA, Salvador P, Dannenberg JJ, Zakrzewski VG, Dapprich S, Daniels AD, Strain MC, Farkas O, Malick DK, Rabuck AD, Raghavachari K, Foresman JB, Ortiz JV, Cui Q, Baboul AG, Clifford S, Cioslowski J, Stefanov BB, Liu G, Liashenko A, Piskorz P, Komaromi I, Martin RL, Fox DJ, Keith T, Al-Laham MA, Peng CY, Nanayakkara A, Challacombe M, Gill PMW, Johnson B, Chen W, Wong MW, Gonzalez C, Pople JA. Gaussian 03®. Wallingford: Gaussian Inc; 2003.

Huey R, Morris GM, Olson AJ, Goodsell DS. J Comput Chem. 2007;28:1145. doi: 10.1002/jcc.20634. PubMed DOI

Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Scalmani G, Barone V, Mennucci B, Petersson GA, Nakatsuji H, Caricato M, Li X, Hratchian HP, Izmaylov AF, Bloino J, Zheng G, Sonnenberg JL, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Vreven T, Montgomery JA, Jr, Peralta JE, Ogliaro F, Bearpark M, Heyd JJ, Brothers E, Kudin KN, Staroverov VN, Keith T, Kobayashi R, Normand J, Raghavachari K, Rendell A, Burant JC, Iyengar SS, Tomasi J, Cossi M, Rega N, Millam JM, Klene M, Knox JE, Cross JB, Bakken V, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Martin RL, Morokuma K, Zakrzewski VG, Voth GA, Salvador P, Dannenberg JJ, Dapprich S, Daniels AD, Farkas O, Foresman JB, Ortiz JV, Cioslowski J, Fox DJ. Gaussian 09 revision A.2. Wallingford: Gaussian Inc; 2009.

Marenich AV, Cramer CJ, Truhlar DG. J Phys Chem B. 2009;113:6378. doi: 10.1021/jp810292n. PubMed DOI

Co-Exposure to Aristolochic Acids I and II Increases DNA Adduct Formation Responsible for Aristolochic Acid I-Mediated Carcinogenicity in Rats

Identification of Human Enzymes Oxidizing the Anti-Thyroid-Cancer Drug Vandetanib and Explanation of the High Efficiency of Cytochrome P450 3A4 in its Oxidation

DNA Adducts Formed by Aristolochic Acid Are Unique Biomarkers of Exposure and Explain the Initiation Phase of Upper Urothelial Cancer